Abstract:Objective To establish the synthesis and purification methods of BSA-(Gd-DTPA)n-CR and conduct its characterization and preliminary evaluation in vivo and in vitro, and to explore its ability to bind to amyloid plaques and application prospect as a high-performance relaxation magnetic resonance imaging agent precursor. Methods BSA-(Gd-DTPA)n-CR was prepared according to previously described protocols on the binding interaction of CR with BSA with several modification. Purification and identification of BSA-(Gd-DTPA)n-CR was performed by using a Sephadex LH20 gel column chromatography and UV spectroscopy. The relaxation rates r1/r2 of the complex were further analyzed by measuring the relaxation time T1/T2 of the complex in vitro. The drug safety was evaluated by acute toxicity test.The coronal T1W images of mouse hearts and livers at different times by a single tail vein injection with BSA-(Gd-DTPA)n-CR were obtained with the Flash 3D sequence.Its ability to bind to amyloid plaques was evaluated by brain sections from APP/PS1 transgenic mice. Its specificity for Aβ plaques was further demonstrated by immunohistochemistry (IHC) staining with the monoclonal antibody to the Aβ protein. Results A novel specific MRI probe precursor BSA-(Gd-DTPA)n-CR based on DTPA-gadolinium (III) and congo red (CR) was successfully synthesized. Meanwhile, the amyloid deposits detected by the BSA-(Gd-DTPA)n-CR were matched to the amyloid deposits detected by Aβ specific antibody. But a few amyloid-like deposits which was not detected by IHC. The findings indicated that the probe perhaps could detect the neurofibrillary tangles (NFT) similar to the effect of CR itself, and this will be verified in future experiments. Conclusions The study suggested that the Aβ protein-specific magnetic resonance contrast agent precursor BSA-(Gd-DTPA)n -CR can be used as a potential fluorescence and MR multi-modal imaging probe precursor to display individual senile plaques in AD.

Detection of Aβ Plaques by a Novel Specific MRI Probe Precursor CR‐BSA‐(Gd‐DTPA)n in APP/PS1 Transgenic Mice

Preparation, characterization and primary evaluation of Aβ protein targeting BSA-(Gd-DTPA)n–CR complex for magnetic resonance contrast enhancement in Alzheimer's disease

[In Vitro Early Detection of Amyloid Plaques in Alzheimer's Disease by Pittsburgh Compound B-modified Magnetic Nanoparticles].

Smart Near-Infrared Fluorescence Probes with Donor–Acceptor Structure for in Vivo Detection of Β-Amyloid Deposits

Amyloid Plaque Imaging with a Targeted MRI Contrast Agent in a Transgenic Mouse Model of Alzheimer’s Disease

Study of Specially Labeling Amyloid Plaques in Vivo in Alzheimer Transgenic Mice with Targeted Magnetic Nano-Iron Contrast Agent

A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease.

D-A-D Fluorogenic Probe for the Rapid Imaging of Amyloid Β Plaques in Vivo

Early Detection of Amyloid Pathology in Alzheimer's Disease by Molecular MRI

Amyloid-β Deposits Target Efficient Near-Infrared Fluorescent Probes: Synthesis, in Vitro Evaluation and in Vivo Imaging.

Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer’s Disease

99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques.

Discovery of a Novel Fluorescent Probe for the Sensitive Detection of Β-Amyloid Deposits.

A Peptide-Based Near-Infrared Fluorescence Probe for Dynamic Monitoring Senile Plaques in Alzheimer's Disease Mouse Model

Synthesis and evaluation of curcumin-based near-infrared fluorescent probes for detection of amyloid β peptide in Alzheimer mouse models

Dicyano-derivatives As Mapping Agents for Peripheric Aβ Plaques in Alzheimer’s Disease Mouse Model

Rational design synthesis and evaluation of a novel near-infrared fluorescent probe for selective imaging of amyloid-β aggregates in Alzheimer's disease

(99M)tc-Labeled Dibenzylideneacetone Derivatives As Potential SPECT Probes for in Vivo Imaging of Β-Amyloid Plaque.

GFP-based Red-Emissive Fluorescent Probes for Dual Imaging of Β-Amyloid Plaques and Mitochondrial Viscosity.

Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease

Curcumin Complex Analogues as Near-Infrared Fluorescent Probes for Monitoring all A beta Species in the Early Alzheimer's Disease Model